Skip to content

Metabolic Effects of Differential Organ Growth Rates

Metabolic Effects of Differential Organ Growth Rates

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03219229
Enrollment
49
Registered
2017-07-17
Start date
2004-02-14
Completion date
2007-02-20
Last updated
2017-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resting Energy Expenditure

Keywords

Fat-free mass, Tanner stage 1, Pre-pubertal

Brief summary

Young children have a high resting energy expenditure (REE) relative to their body weight and metabolically active compartment, fat-free mass (FFM). Both body weight and FFM are, however, metabolically heterogeneous and include organs and tissues varying widely in specific metabolic rate (i.e., organ REE/kg/d). One prevailing hypothesis is that most, if not all, of the higher REE observed in young animals and children compared to adults can be accounted for by a larger proportion of high metabolic rate components such as brain, liver, and heart..

Detailed description

FFM was the traditional and only means of adjusting REE for between-individual differences in metabolically active tissue components. The investigators seek to improve the understanding of variation in REE by developing new and improved rapid magnetic resonance imaging (MRI) methods of quantifying some of the major heat producing organs and tissues in children and adults. The long-term aim is to provide an improved understanding of human energy requirements. Specifically, the investigators propose to test whether: 1) a portion of the elevated daily REE adjusted for FFM observed in young children (Tanner Stage 1) could be accounted for by the relative fractions of body mass as high metabolic activity tissues (heart, liver, kidney, brain) and low metabolic activity tissues (skeletal muscle, adipose tissue), 2) a portion of the age-related decline in daily REE adjusted for FFM observed in children could be accounted for by changes in the relative fractions of body mass as high and low metabolic rate tissues during growth.

Interventions

None listed

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 11 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Aged from 7-11 years * Pre-pubertal (based on Tanner staging) * Africa-American, Asian, and Caucasian (by self-report of all 4 grandparents of same race group)

Exclusion criteria

* Actively involved in a weight management program * Have co-morbidities of obesity (Blounts disease, hypertension, diabetes; sleep apnea) * Have entered puberty * Precocious puberty * Have known metabolic abnormalities * Were born prematurely, or were small or large for gestational age * Lean individuals who have a family history (parents or siblings) of obesity or Type 2 diabetes * Current or previous significant use of any medication known to affect any of the variables being measured

Design outcomes

Primary

MeasureTime frameDescription
Variability in resting energy expenditureDay 1The collected measures will be aggregated to statistically test the following question: How much of the variability in resting energy expenditure can be accounted for by the mass of the measured organs (liver, kidneys, spleen, heart) and tissues (fat, skeletal muscle, brain) and is the explained variance greater than the variance explained when predicting resting energy explained from a model using fat and fat-free mass alone.
Weight in kilogramsDay 1Measured using a calibrated scale
Liver in kilogramsDay 1Total volume measured by MRI
Fat-free mass in kilogramsDay 1Measured from a whole-body dual energy X-ray absorptiometry (DXA) scan
Height in metersDay 1Measured using a stadiometer
Resting energy expenditure in kilocaloriesDay 1REE is measured by indirect calorimetry over a 30 minute period and extrapolated to a 24 hour period
Fat mass in kilogramsDay 1Measured from a whole-body dual energy X-ray absorptiometry (DXA) scan
Heart in kilogramDay 1Left ventricular mass measured by cardiac gated MRI
Kidneys in kilogramDay 1Total volume measured by MRI
Spleen in kilogramsDay 1Total volume measured by MRI
Trunk high metabolic rate organs in kilogramsDay 1The sum of liver, kidneys, spleen, and heart
Brain mass in kilogramDay 1Total volume measured by MRI
Skeletal muscle mass in kilogramsDay 1Skeletal muscle volume measured by MRI
Residual fat-free mass in kilogramsDay 1Fat-free mass minus the sum of kidneys, liver, spleen, heart, and skeletal muscle
Total body adipose tissue mass in kilogramDay 1Represents the sum of visceral, subcutaneous, and intermuscular adipose tissue by MRI
Body mass index in kg/m2Day 1Weight and height will be combined to report BMI

Secondary

MeasureTime frameDescription
Change in resting energy expenditure in relation to changes in body composition and organ mass.From baseline measure to follow-up, approximately 2 yearsA portion of age-related decline (2-years) in daily REE adjusted for FFM observed in children is explainable in part by changes in the relative fractions of body mass as high (brain, heart, liver, kidney) and low (skeletal muscle, adipose tissue) metabolic activity tissues with growth and pubertal progress

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026